HOUSTON ― Researchers at The University of Texas MD Anderson Cancer Center have developed a new approach to engineering natural killer (NK) cells with a second chimeric antigen receptor (CAR) to act ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results